Imaging With [11C]Martinostat in Breast Cancer

• Status: Withdrawn
• Trial end date: 2024-10-31

Summary

This research study is studying a PET imaging tracer as a possible means of imaging breast cancer.

The imaging agent involved in this study is:

-[11C]Martinostat (called C-eleven-Martinostat)

• Phase: Phase 1

Details

• Lead Sponsor: Christine Elizabeth Edmonds